Joint Safety with Tanezumab: Integrated Analyses from Randomized Controlled Phase 3 Studies in Patients with Osteoarthritis John A. Carrino, MD, M.P.H. – Hospital for Special Surgery
4:10 PM – 4:20 PM ET
A Randomised Controlled Trial Evaluating the Efficacy of Internet-based Exercises Aimed at Treating Knee Osteoarthritis (iBEAT-OA) Sameer A. Gohir, BSc, PT, MSc – NIHR Nottingham Biomedical Research Centre
4:20 PM – 4:30 PM ET
Efficacy of Tocilizumab in Patients with Hand Osteoarthritis: Double Blind, Randomized, Placebo Controlled, Multicenter Trial Pascal Richette – Lariboisiere Hospital
4:30 PM – 4:40 PM ET
LNA043, a Novel Cartilage Regenerative Treatment for Osteoarthritis: Results from a First-In-Human Trial in Patients with Knee Osteoarthritis Jörg Goldhahn, MD – Department of Health Sciences and Technology, ETH Zürich
4:40 PM – 4:50 PM ET
Long-term Efficacy and Safety of Intra-articular Sprifermin in Patients with Knee Osteoarthritis: Results from the 5-Year Forward Study Marc Hochberg, MD, MPH – University of Maryland School of Medicine
